Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders



Status:Active, not recruiting
Conditions:Anxiety, Anxiety, Depression, Insomnia Sleep Studies, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:10/13/2018
Start Date:June 11, 2018
End Date:November 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Nexalin Electrical Brain Stimulation as an Adjunctive Therapy for Substance Dependence

The purpose of this research study is to determine whether Nexalin Trans-cranial Electrical
Stimulation (TES) is a viable adjunctive treatment of substance use treatments.

A Randomized Controlled Trial with block randomization. Inpatient subjects actively seeking
substance abuse treatment at the Carrier Clinic who are diagnosed with a substance use
disorder, including alcohol use disorder, tobacco use disorder, polysubstance use disorder,
or other substance use disorder.

Inclusion Criteria:

1. Be able to provide informed consent, assessed by the study clinician

2. Be able to speak, read and write fluently in English, assessed by the study clinician

3. Be committed to completion of the study. The subject will need to attest to
availability for 10 to 15 treatments over a 5 to 8 day period for the treatment
protocol.

4. Be adults over age 18 and under age 65

5. Be actively receiving substance use treatment for a substance use disorder

Exclusion Criteria:

1. Pregnant or at risk of becoming pregnant

2. Individual has a condition the Investigator believes would interfere with his or her
ability to provide informed consent, comply with the study protocol, might confound
the interpretation of the study results, or put the person at undue risk
We found this trial at
1
site
Carrier Clinic
Belle Mead, New Jersey 08502
?
mi
from
Belle Mead, NJ
Click here to add this to my saved trials